KRAS and glioblastoma: In addition to TGF-β, we also noted significant modulation of ERK/MAPK1/2 phosphoprotein levels, which was correlated with significant enrichment of the KRAS signaling pathway in transcriptomic analysis; this may be significant given the role of RAS signaling in oncology and GBM [59].